[1] Hou J, Tian J, Jiang W, Gao Y, Fu F.
Therapeutic effects of SMND-309, a new metabolite of salvianolic acid B, on experimental liver fibrosis.
Eur J Pharmacol. 2011 Jan 10;650(1):390-5. DOI:
10.1016/j.ejphar.2010.10.019[2] Yang J, Zhang G, Tian J, Li C, Jiang W, Xing Y, Zhu H, Hou J, Xu H, Wu J.
Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in rats.
Basic Clin Pharmacol Toxicol. 2010 Apr;106(4):317-23. DOI:
10.1111/j.1742-7843.2009.00490.x[3] Wang Y, Zhang J, Han M, et al. SMND-309 promotes neuron survival through the activation of the PI3K/Akt/CREB-signalling pathway. Pharm Biol. 2016;54(10):1982-1990. DOI:
10.3109/13880209.2015.1137951 
